Amedisys, Inc. (AMED)

Amedisys Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	85.63	43.23	-9.75	118.61	209.07	183.61
Depreciation & Amortization	61.75	60.46	57.64	68.86	71.27	67.94
Other Amortization	0.94	0.99	0.99	0.99	0.92	0.87
Loss (Gain) From Sale of Assets	-1.68	-1.65	2.51	0.52	-0.12	-0.03
Asset Writedown & Restructuring Costs	49.27	48.39	0.2	5.11	-	4.15
Loss (Gain) From Sale of Investments	-51.66	-	-	-	-31.1	2.98
Loss (Gain) on Equity Investments	-0.99	-2.64	-5.69	5.21	0.39	1.48
Stock-Based Compensation	29.2	30.64	29.02	16.56	23.81	26.73
Other Operating Activities	13.48	2.35	125.47	22.47	45.68	-25
Change in Accounts Receivable	61.39	16.48	-26.73	-14.23	-18.03	2.11
Change in Accounts Payable	4.1	12.21	-15.82	4.89	-4.35	1.94
Change in Other Net Operating Assets	-12	11.21	-20.66	-95.71	-108.64	22.17
Operating Cash Flow	239.43	221.67	137.19	133.28	188.89	288.95
Operating Cash Flow Growth	148.80%	61.58%	2.93%	-29.44%	-34.63%	43.05%

Investing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Capital Expenditures	-4.41	-6.55	-5.62	-6.17	-6.3	-5.33
Sale of Property, Plant & Equipment	0.02	-	0.14	0.07	0.14	0.08
Cash Acquisitions	-	-	-0.35	-71.95	-269.97	-298.96
Divestitures	-	-	47.79	-	-	-
Sale (Purchase) of Intangibles	-0.84	-0.82	-7.09	-1.05	-0.42	-
Investment in Securities	-0.85	-1.05	0.15	-15.64	-5.2	17
Other Investing Activities	0.06	0.06	0.05	0.25	0.14	0.1
Investing Cash Flow	-6.02	-8.36	35.06	-94.49	-281.61	-287.11

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Short-Term Debt Issued	-	-	23	534.5	-	-
Long-Term Debt Issued	-	-	-	-	791.01	684.2
Total Debt Issued	-	-	23	534.5	791.01	684.2
Short-Term Debt Repaid	-	-	-23	-534.5	-	-
Long-Term Debt Repaid	-	-37.36	-76.01	-13.3	-560.84	-713.45
Total Debt Repaid	-38.53	-37.36	-99.01	-547.8	-560.84	-713.45
Net Debt Issued (Repaid)	-38.53	-37.36	-76.01	-13.3	230.17	-29.25
Issuance of Common Stock	0.46	0.31	2.7	6.15	6.02	9.89
Repurchase of Common Stock	-7.96	-6.15	-6.53	-25.33	-116.78	-54.49
Other Financing Activities	-7.43	-5.72	-7.68	2.04	-64.29	58.88
Financing Cash Flow	-53.46	-48.92	-87.52	-30.43	55.13	-14.98

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Cash Flow	179.95	164.38	84.73	8.36	-37.59	-13.13

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Free Cash Flow	235.02	215.12	131.57	127.12	182.59	283.62
Free Cash Flow Growth	163.17%	63.50%	3.50%	-30.38%	-35.62%	46.11%
Free Cash Flow Margin	9.78%	9.16%	5.88%	5.72%	8.25%	13.69%
Free Cash Flow Per Share	7.08	6.51	4.04	3.89	5.54	8.53
Levered Free Cash Flow	300.69	277.51	258.61	122.2	112.9	368.1
Unlevered Free Cash Flow	317	295.74	277.17	135.1	117.93	374.13

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash Interest Paid	26.84	29.99	29.77	27.69	5.29	6.21
Cash Income Tax Paid	47.03	40.1	29.13	24.01	34.1	50.72
Change in Working Capital	53.49	39.9	-63.21	-105.04	-131.02	26.22

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error